Characterization of Immune Cell Subset Expansion in Response to Therapeutic Treatment in Mice

Jakub Tomala1,2,3, Jamie B Spangler4,5

  • 1Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.

Insights

This study presents a flow cytometry workflow to rapidly assess immune cell activation in mice. This method offers a powerful tool for evaluating potential immunotherapeutics across various disease applications.

Area of Science:

  • Molecular Immunology
  • Cellular Biology
  • Immunotherapy Research

Background:

  • Flow cytometry is crucial for analyzing immune events at the single-cell level.
  • Evaluating new immunotherapeutics often requires complex, long-term animal models.
  • There is a need for faster methods to assess immune responses to molecular interventions.

Purpose of the Study:

  • To describe a flow cytometry-based workflow for quantifying immune cell subset activation in mice.
  • To provide a rapid alternative to traditional disease models for evaluating candidate therapeutics.
  • To demonstrate the utility of this approach for both immunostimulatory and immunosuppressive therapeutic strategies.

Main Methods:

  • Utilized flow cytometry to monitor immune cell activation in mice.
  • Developed a workflow for quantifying specific immune cell subsets.
  • Applied the method to assess responses to molecular interventions in vivo.

Main Results:

  • The flow cytometry workflow enables rapid quantification of immune cell activation.
  • This technique allows for efficient preliminary assessment of immunotherapeutic candidates.
  • The approach is versatile, applicable to diverse disease contexts requiring immune modulation.

Conclusions:

  • This flow cytometry workflow is a powerful and accessible strategy for preliminary in vivo assessment of immunotherapeutics.
  • The method facilitates faster evaluation of potential treatments for conditions like cancer, infectious diseases, autoimmune disorders, and transplantation.
  • This technique streamlines the early-stage research and development of novel immunotherapies.

Related Concept Videos